Phathom Independent Medical Education (IME) Grants — symptomatic GERD, GI-focused HCPs

About this program

Phathom Pharmaceuticals supports Independent Medical Education (IME) grants for U.S.-based IME programs focused on symptomatic GERD and targeting gastroenterology-focused healthcare providers. The company’s 2025 IME budget is exhausted; Phathom will not accept 2026 IME requests until December 1, 2025, and will not release funds before January 1, 2026. In 2026 funding is restricted to regional and society programs with awards capped at $15,000 per request and applications must be submitted via Phathom’s Medical Affairs IME Grants portal. Eligible applicants are U.S.-based organizations conducting non-promotional medical education for GI-focused HCPs and must meet Phathom’s scope, submission materials, and independence/compliance requirements.